Home
Agenda
Tuesday, April 6th |
||
| 4:00–6:00 pm | Conference Registration and Networking | |
| 6:00–7:30 pm | Opening Reception | |
Wednesday, April 7th |
||
| 7:30–8:30 am | Networking Breakfast | |
| 8:30–8:45 am | Welcome and Opening Remarks | |
| Welcome | Anthony Atala, MD, Wake Forest Institute for Regenerative Medicine |
|
| Al Delia, Chairman of the Innovation Council Office of Governor Beverly Perdue |
||
| 8:45–9:15 am | What Is the Promise of Regenerative Medicine? | |
| Format: Panel | ||
| Moderator | John E. Abele, Founding Chairman, Retired, Boston Scientific Corporation |
|
| Panelist | Alan J. Lewis, PhD, Juvenile Diabetes Research Foundation International |
|
| Panelist | John Walker, iPierian | |
| Panelist | Andrew von Eschenbach, MD, Greenleaf Health LLC and Center for Health Transformation Former US FDA Commissioner |
|
| Panelist | Gary J. Kurtzman, MD, Safeguard Scientifics |
|
| 9:15–10:00 am | The Translational Imperative: Deliver the Promise | |
| Format: Panel | ||
| Moderator | Lesa Mitchell, Kauffman Foundation |
|
| Panelist | Brock Reeve, MPhil, MBA, Harvard Stem Cell Institute |
|
| Panelist | Scott Weir, PharmD, PhD, University of Kansas, Institute for Advancing Medical Innovation |
|
| Panelist | Rick Blume, Excel Medical Ventures | |
| 10:00–10:30 am | Networking Break | |
| 10:30–11:15 am | The Science: What’s Next for the Clinic? | |
| Format: Plenary, Keynote Address | Robert Lanza, MD, Advanced Cell Therapy |
|
| 11:15 am–noon | Bridging: From the Bench to the Bedside | |
| Format: Panel | ||
| Moderator | Michael J. Werner, Holland & Knight |
|
| Panelist | Bernard Siegel, Genetics Policy Institute |
|
| Panelist | COL Janet R. Harris, PhD, MSN, AFIRM Congressionally Directed Medical Research Programs |
|
| Panelist | DaLaura L.S. Kader, Regenerative Medicine Foundation |
|
| Panelist | Michelle McMurry-Heath, MD, PhD, The Aspen Institute |
|
| Panelist | Rosemarie Hunziker, PhD, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health |
|
| noon–12:30 pm | Lunch | |
| 12:30–1:15 pm | A Funding Model for Translational Medicine | |
| Format: Keynote Address | Robert Klein, California Institute for Regenerative Medicine (CIRM) |
|
| 1:15–2:00 pm | Integrative Commercialization Strategies | |
| Format: Panel | ||
| Moderator | Scott R. Burger, MD, Advanced Cell & Gene Therapy |
|
| Panelist | Stephen Minger, PhD, GE Healthcare |
|
| Panelist | Steven R. Bauer, PhD, US Food and Drug Administration |
|
| Panelist | Vincent Ronfard, PhD, Organogenesis |
|
| Panelist | Joydeep Goswami, PhD, MBA, Life Technologies |
|
| Panelist | Tim Bertram, DVM, PhD, Tengion | |
| 2:00–2:45 pm | Regulatory and Reimbursement Strategies | |
| Format: Panel | ||
| Moderator | Andrew von Eschenbach, MD, Greenleaf Health LLC and Center for Health Transformation Former US FDA Commissioner |
|
| Panelist | Steven R. Bauer, PhD, US Food and Drug Administration |
|
| Panelist | Anthony Ratcliffe, PhD, Synthasome |
|
| Panelist | Richard E. Caruso, PhD, Integra | |
| 2:45–3:15 pm | International Best Practices in Regenerative Medicine | |
| Format: Panel | ||
| Moderator | David F. Williams, DSc, FREng, Wake Forest Institute for Regenerative Medicine |
|
| Panelist | Prof. Chunren Wang, National Institute for the Control of Pharmaceutical and Biological Products |
|
| Panelist | COL Robert Vandre, DDS, AFIRM | |
| Panelist | Mime Egami, PhD, Tokyo Women’s Medical University |
|
| 3:15–3:35 pm | Networking Break | |
| 3:35–5:30 pm | Scientific Discovery | |
| Format: Podium Presentations | ||
| Host and Presenter | Buddy D. Ratner, PhD, University of Washington |
|
| Presenter | Teruo Okano, PhD, Tokyo Women’s Medical University |
|
| Presenter | Jennifer H. Elisseeff, PhD, Johns Hopkins University |
|
| Presenter | Jack Kessler, MD, Northwestern University |
|
| Presenter | G. Sitta Sittampalam, PhD, University of Kansas, Institute for Advancing Medical Innovation |
|
| Presenter | Douglas Losordo, MD, FACC, Northwestern University | |
| Presenter | Simon Cool, PhD, A*STAR Singapore |
|
| Presenter | B. Lynn Allen-Hoffmann, PhD, Stratatech Corporation |
|
| Presenter | Yilin Cao, MD, PhD, Shanghai Jiao Tong University |
|
| 5:30–6:30 pm | Networking Reception | |
| Poster Session | ||
| 7:00–8:30 pm | Gala Dinner | |
| Keynote Address: | Juan Enriquez, Excel Venture Management |
|
Thursday, April 8th |
||
| 7:00–8:00 am | Breakfast and Venture Forum I | |
| Company | Arterion | |
| Company | Articular Engineering | |
| Company | Creative Bioreactor Designs, Inc. | |
| Company | ISTO Technologies | |
| Company | KeraNetics | |
| Company | Kryosphere | |
| Company | Southern Access Technologies | |
| Company | Ventrix | |
| 8:00–8:30 am | Translational Medicine in the Military | |
| Format: Plenary, Keynote Address | ||
| Lieutenant General Eric B. Schoomaker, MD, PhD, US Army Medical Command |
||
| 8:30–9:15 am | Best Practices in Commercialization | |
| Format: Panel | ||
| Moderator | R. Lee Buckler, BEd, LLB, Cell Therapy Group |
|
| Panelist | Anthony Caggiano, MD, PhD, Acorda Therapeutics |
|
| Panelist | Dean Tozer, Advanced BioHealing |
|
| Panelist | Ed Field, Aldagen | |
| Panelist | Robert Deans, PhD, Athersys | |
| Panelist | Richard S. Stack, MD, FACC, Synecor |
|
| 9:15–9:45 am | Commercial Capacity and Tools | |
| Format: Panel | ||
| Moderator | Edmund “Morrie” Ruffin, MA, Adjuvant Global Advisors |
|
| Panelist | Raymond H. Cypess, DVM, PhD, ATCC |
|
| Panelist | Joseph DeSimone, PhD, Liquidia Technologies |
|
| Panelist | Kurt Last, Specialty Operations Solutions |
|
| Panelist | David S. Smith, Pepper Hamilton LLP |
|
| 9:45–10:20 am | Venture Panel I: Designing the Deal | |
| Format: Panel | ||
| Moderator | Jeff Karan, MBA Proteus Ventures Partners |
|
| Panelist | Garheng Kong, MD, PhD, Intersouth Partners |
|
| Panelist | Frank Douglas, MD, PhD, Pure Tech Ventures, Austen BioInnovation Inst. in Akron, Kauffman Foundation |
|
| Panelist | Mostafa Analoui, PhD, Livingston Group |
|
| Panelist | Gail K. Naughton, PhD, Histogen |
|
| 10:20–11:00 am | Venture Panel II: Capturing Value for Capital Markets | |
| Format: Panel | ||
| Panelist | Jay Watkins, De Novo Ventures |
|
| Panelist | Scott Livingston, Livingston Securities |
|
| Panelist | Rick Blume, Excel Medical Ventures |
|
| Panelist | P. Sherrill Neff, Quaker BioVentures |
|
| Panelist | David Scheer, Scheer & Company |
|
| 11:00–11:15 am | Networking Break | |
| 11:15 am–12:55 pm | Venture Forum II | |
| Company | ACell | |
| Company | Avita Medical | |
| Company | Bioheart | |
| Company | Healionics | |
| Company | Juventas Therapeutics | |
| Company | Ocular Systems | |
| Company | PharmInova | |
| Company | Soft Tissue Regeneration | |
| Company | America Stem Cell | |
| Company | Axerion Therapeutics | |
| 12:55–1:00 pm | Wrap Up and Adjourn Meeting | Anthony Atala, MD, Wake Forest Institute for Regenerative Medicine |
